Lars-Goran Carlsson
- Risks of diabetes mellitus and hyperglycaemic adverse events in patients with asthma taking inhaled corticosteroidsBy Paul O'Byrne, Stephen Rennard, Radner Finn, Stefan Peterson, Lars-Goran Carlsson and Don SinPaul O'Byrne1Michael G DeGroote School of Medicine, McMaster University, Hamilton, CanadaStephen Rennard2Internal Medicine Section of Pulmonary and Critical Care, Nebraska Medical Center, NE, United StatesRadner Finn3Clinical Sciences, AstraZeneca R&D, Lund, SwedenStefan Peterson3Clinical Sciences, AstraZeneca R&D, Lund, SwedenLars-Goran Carlsson3Clinical Sciences, AstraZeneca R&D, Lund, SwedenDon Sin4Department of Medicine, University of British Columbia, Vancouver, Canada
- Tolerability and efficacy of budesonide/formoterol via Turbuhaler® vs standard treatment in Japanese patients with moderate to severe COPD: 52-week phase III study resultsBy Masakazu Ichinose, Hiroyuki Nakamura, Noriharu Shijubo, Takefumi Saito, Hiroyuki Taniguchi, Toru Tsuda, Kosho Yoshikawa and Lars-Goran CarlssonMasakazu Ichinose1Third Department of Internal Medicine, Wakayama Medical University, Wakayama, JapanHiroyuki Nakamura2Department of Medicine, Sakaide City Hospital, Kagawa, JapanNoriharu Shijubo3Department of Medicine, JR Sapporo Hospital, Hokkaido, JapanTakefumi Saito4Department of Respiratory Medicine, National Hospital Organization Ibarakihigashi National Hospital, Ibaraki, JapanHiroyuki Taniguchi5Department of Medicine, Tosei General Hospital, Aichi, JapanToru Tsuda6Department of Medicine, Kirigaota Tsuda Hospital, Fukuoka, JapanKosho Yoshikawa7Department of Medicine, Daido Hospital, Aichi, JapanLars-Goran Carlsson8Clinical Sciences, AstraZeneca R&D, Molndal, Sweden
- Budesonide/formoterol vs formoterol, both via Turbuhaler®, in patients with moderate to severe COPD: Phase III study resultsBy Masakazu Ichinose, Ronnie Samoro, Rustem Fassakhov, Mitsuru Oguri, Jan Ekelund, Lars-Goran Carlsson and Yoshinosuke FukuchiMasakazu Ichinose1Third Department of Internal Medicine, Wakayama Medical University, Wakayama, JapanRonnie Samoro2Department of Medicine, Healthlink Medical-Surgical-Dental Clinics and Diagnostic Center, Iloilo City, PhilippinesRustem Fassakhov3Department of Medicine, Institute of Epidemiology and Microbiology, Kazan, Russian FederationMitsuru Oguri4Department of Medicine, Oji General Hospital, Hokkaido, JapanJan Ekelund5Clinical Sciences, AstraZeneca R&D, Molndal, SwedenLars-Goran Carlsson5Clinical Sciences, AstraZeneca R&D, Molndal, SwedenYoshinosuke Fukuchi6Department of Respiratory Medicine, Juntendo University, Tokyo, Japan
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.